LYELL IMMUNOPHARMA INC (LYEL) Stock Earnings & Estimates
USA - NASDAQ:LYEL - US55083R2031 - Common Stock
16.71 USD
-0.52 (-3.02%)
16.71 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 84.68M 695.12% | 130K -99.85% | 61K -53.08% | 10.71K -82.44% | -100.00% | 3.825M | 45.696M 1,094.67% | 103.02M 125.45% | |
| EBITDA YoY % growth | -169.04M 15.84% | -226.758M -34.14% | -200.643M 11.52% | -200.56M 0.04% | -228.882M -14.12% | -306.604M -33.96% | N/A | N/A | |
| EBIT YoY % growth | -187.06M 12.78% | -247.008M -32.05% | -220.274M 10.82% | -208.687M 5.26% | -233.077M -11.69% | -269.127M -15.47% | -361.794M -34.43% | -353.124M 2.40% | |
| Operating Margin | -220.90% | -190,006.15% | -361,104.92% | -1,948,520.67% | N/A | -7,036.00% | -791.74% | -342.77% | |
| EPS YoY % growth | -15.00 45.67% | -15.60 -4.00% | -15.80 -1.28% | -11.71 25.91% | -11.22 4.15% | -9.36 16.55% | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.70 20.73% | -2.68 33.00% | -2.99 15.43% | -3.12 -8.00% | -3.65 -35.48% | -3.95 -47.29% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | -100.00% | ||
| EBITDA Q2Q % growth | -50.212M -39.87% | -52.116M -21.10% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -49.401M 2.19% | -51.365M 18.03% | -53.805M 6.21% | -55.692M -24.77% | -57.12M -15.62% | -61.2M -19.15% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -2.89 19.72% | -3.65 | 0.76 | 20.93% |
| Q1 2025 Q2Q % growth | -3.54 26.25% | -3.67 | 0.13 | 3.59% |
| Q4 2024 Q2Q % growth | -4.00 | -3.47 | -0.53 | -15.34% |
| Q3 2024 Q2Q % growth | -3.40 | -4.08 | 0.68 | 16.67% |
| Q2 2024 Q2Q % growth | -3.60 | -4.18 | 0.58 | 13.92% |
| Q1 2024 Q2Q % growth | -4.80 -4.35% | -4.28 | -0.52 | -12.04% |
| Q4 2023 Q2Q % growth | -4.00 -400.00% | -4.65 | 0.65 | 14.00% |
| Q3 2023 Q2Q % growth | -3.40 39.29% | -5.10 | 1.70 | 33.33% |
| Q2 2023 Q2Q % growth | -3.60 -20.00% | -5.58 | 1.98 | 35.44% |
| Q1 2023 Q2Q % growth | -4.60 17.86% | -5.78 | 1.18 | 20.41% |
| Q4 2022 Q2Q % growth | -0.80 88.57% | -6.19 | 5.39 | 87.07% |
| Q3 2022 Q2Q % growth | -5.60 -40.00% | -6.32 | 0.72 | 11.45% |
| Q2 2022 Q2Q % growth | -3.00 83.15% | -6.32 | 3.32 | 52.56% |
| Q1 2022 Q2Q % growth | -5.60 | -5.85 | 0.25 | 4.24% |
| Q4 2021 Q2Q % growth | -7.00 | -5.61 | -1.39 | -24.78% |
| Q3 2021 Q2Q % growth | -4.00 | -5.51 | 1.51 | 27.38% |
| Q2 2021 Q2Q % growth | -17.80 | -7.45 | -10.35 | -139.05% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 8K -38.46% | 8K | % | |
| Q1 2025 Q2Q % growth | 7K 133.33% | 7K | % | |
| Q4 2024 Q2Q % growth | 11K -15.38% | 11K | % | |
| Q3 2024 Q2Q % growth | 34K 36.00% | 34K | % | |
| Q2 2024 Q2Q % growth | 13K -51.85% | 13K | % | |
| Q1 2024 Q2Q % growth | 3K -95.38% | 3K | % | |
| Q4 2023 Q2Q % growth | 13K -99.97% | 13K | % | |
| Q2 2023 Q2Q % growth | 27K -99.92% | 27K | % | |
| Q1 2023 Q2Q % growth | 65K -88.18% | 65K | % | |
| Q4 2022 Q2Q % growth | 48.39M 1,615.96% | 1.904M | 46.486M | 2,441.49% |
| Q3 2022 Q2Q % growth | -100.00% | 1.836M | -1.836M | -100.00% |
| Q2 2022 Q2Q % growth | 35.74M 1,258.94% | 1.088M | 34.652M | 3,184.93% |
| Q1 2022 Q2Q % growth | 550K -77.55% | 1.02M | -470K | -46.08% |
| Q4 2021 Q2Q % growth | 2.82M 22.08% | 2.907M | -87K | -2.99% |
| Q3 2021 Q2Q % growth | 2.76M 157.94% | 2.346M | 414K | 17.65% |
| Q2 2021 Q2Q % growth | 2.63M -15.71% | 2.295M | 335K | 14.60% |
| Q1 2021 Q2Q % growth | 2.45M 94.44% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.79% | 27.27% | 3.68% | 25.77% |
| Revenue | N/A | N/A | -25% | 23.53% |